Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Narcisa Mesaros"'
Autor:
Ana Florea, Lina S. Sy, Bradley K. Ackerson, Lei Qian, Yi Luo, Tracy Becerra-Culqui, Gina S. Lee, Yun Tian, Chengyi Zheng, Radha Bathala, Sara Y. Tartof, Laura Campora, Maria Angeles Ceregido, Anastasia Kuznetsova, Jean-Etienne Poirrier, Dominique Rosillon, Laura Valdes, Brigitte Cheuvart, Narcisa Mesaros, Nadia Meyer, Adrienne Guignard, Hung-Fu Tseng
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 2, Pp 411-423 (2022)
Abstract Introduction This observational retrospective matched cohort study evaluated the safety of a prenatal tetanus, diphtheria, acellular pertussis (Tdap) vaccination, Boostrix. We previously reported on the risk of maternal and neonatal outcomes
Externí odkaz:
https://doaj.org/article/0dcc886106894a17b434b8a2bfb5ab2d
Autor:
Mauro Sancovski, Narcisa Mesaros, Yang Feng, M. Angeles Ceregido, Dominique Luyts, Eliana De Barros
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 12, Pp 2873-2881 (2019)
Reduced antigen diphtheria-tetanus-acellular pertussis (Tdap) vaccination is included in the maternal immunization program in Brazil since September 2014. We investigated associations between maternal Tdap vaccination and pregnancy-related adverse ev
Externí odkaz:
https://doaj.org/article/689b41936bf7443d8b8a39fbca2cc0c9
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 809-821 (2019)
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further reduce the number of injections in pediatric immunization schedules of countries
Externí odkaz:
https://doaj.org/article/1776b521af0141ba8aeb3bf2c2968671
Autor:
Nicola P. Klein, Remon Abu-Elyazeed, Yaela Baine, Brigitte Cheuvart, Marcela Silerova, Narcisa Mesaros
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 2, Pp 327-338 (2019)
This phase III, open-label, randomized study (NCT01978093) evaluated the immunogenicity and safety of co-administered Haemophilus influenzae type b–Neisseria meningitidis serogroups C and Y–tetanus toxoid conjugate vaccine (Hib-MenCY-TT) with hum
Externí odkaz:
https://doaj.org/article/caf031fb117c49a692ba1fd070ce7e25
Autor:
Ki Hwan Kim, Chun Soo Kim, Hwang Min Kim, Jong-Duck Kim, Sang Hyuk Ma, Dong Ho Kim, Pyoung-Han Hwang, Ji-Whan Han, Taek-Jin Lee, Joon Hyung Kim, Naveen Karkada, Narcisa Mesaros, Woo-Yun Sohn, Jong-Hyun Kim
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 2, Pp 317-326 (2019)
We assessed the immunogenicity and safety of a three-dose primary vaccination schedule with the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in Korean infants. In this pha
Externí odkaz:
https://doaj.org/article/c575118217734c12a8a4696e16dd74e4
Autor:
Tino F. Schwarz, Ulrich Behre, Thomas Adelt, Matthias Donner, Pemmaraju V. Suryakiran, Winnie Janssens, Narcisa Mesaros, Falko Panzer
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 1, Pp 235-241 (2019)
We evaluated antibody persistence against hepatitis B virus (HBV) in adolescents previously vaccinated with a hexavalent diphtheria-tetanus-acellular pertussis-HBV-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine (DTPa-HBV-IPV/H
Externí odkaz:
https://doaj.org/article/49f1fb2f8a7d468dad1697e7a43c639b
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 8, Pp 1977-1986 (2018)
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an increasing number of outbreaks have been observed over the last decades. The reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine (Tdap) can be u
Externí odkaz:
https://doaj.org/article/e428885c97f94887b395715bd9fb662d
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 6, Pp 513-524 (2018)
Introduction: Combination vaccines improve vaccine uptake and open the infant immunization space for additional vaccines. Hexavalent vaccines have been marketed since 2000. Infanrix hexa (combined diphtheria-tetanus-acellular pertussis-hepatitis B-in
Externí odkaz:
https://doaj.org/article/b8c6b23faa914a598233bab88b23d98f
Autor:
Timo Vesikari, Luis Rivera, Tiina Korhonen, Anitta Ahonen, Brigitte Cheuvart, Marjan Hezareh, Winnie Janssens, Narcisa Mesaros
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 7, Pp 1505-1515 (2017)
Safety and immunogenicity of 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens of the combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Hib vaccine (DTPa-HBV-IPV/Hib)
Externí odkaz:
https://doaj.org/article/772d0d12fba84749a5eb7dcd8590367d
Autor:
Yanping Li, Rong Cheng Li, Qiang Ye, Changgui Li, You Ping Liu, Xiao Ma, Yanan Li, Hong Zhao, Xiaoling Chen, Deepak Assudani, Naveen Karkada, Htay Htay Han, Olivier Van Der Meeren, Narcisa Mesaros
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 3, Pp 588-598 (2017)
We conducted 3 phase III, randomized, open-label, clinical trials assessing the safety, reactogenicity (all studies), immunogenicity (Primary vaccination study) and persistence of immune responses (Booster study) to the combined diphtheria, tetanus,
Externí odkaz:
https://doaj.org/article/fb921f0885c8412fb3ac19e42dce9a4e